Rob Labriola

Rob Labriola has extensive experience in regulatory operations within the pharmaceutical industry. Currently serving as Executive Director of Regulatory Operations at Syndax Pharmaceuticals since December 2024, Rob has held similar executive roles at Garuda Therapeutics and Certara Synchrogenix. Their prior positions include Senior Director roles at Flexion Therapeutics and Certara Synchrogenix, and Director of Global Regulatory Operations at Alexion Pharmaceuticals. Rob's career began in regulatory positions at Millennium Pharmaceuticals and Janssen Pharmaceutica, following independent consulting in the life sciences sector. Additionally, Rob contributed to academia as a Faculty/Senior Fellow at the National Defense University.